Total and free testosterone in plasma of hypo- and agonadal men
- PMID: 1227846
Total and free testosterone in plasma of hypo- and agonadal men
Abstract
Plasma total testosterone (T), apparently free T and testosterone binding globulin (TeBG) capacity determined in 14 normal men aged 30-40 years were 461 +/- 100 ng/100 ml, 9.4 +/- 3.0 ng/100 ml and 5.7 +/- 1.9 X 10(-8) M, respectively, whereas in 16 hypogonadal men the corresponding values were 38.6 +/- 27.2 ng/100 ml, 0.47 +/- 0.41 ng/100 ml and 10.4 +/- 3.4 X 10(-8) M showing the TeBG capacity significantly higher (p less than 0.001) in hypogonadal than in normal men. Treatment of 5 hypogonadal subjects with 250 mg testosterone enanthate plus 50 mg testosterone propionate decreased (p less than 0.001) the TeBG level from 14.7 +/- 2.5 X 10(-8YM to 8.3 +/- 1.4 X 10(-8) M on day 8 after a single injection. According to this difference in TeBG, the free T fraction in plasma rose from 0.94% to 1.9% of the total T concentration. These results suggest that alteration of total plasma T affected the TeBG capacity. Decreased T levels raised and increased T concentrations suppressed TeBG, but with a delayed response to the changed T concentrations. The initial mean values in 12 patients with prostatic cancer aged 60-74 years were 397 +/- 165 ng/100 ml, 4.05 +/- 1.8 ng/100 ml and 11.9 +/- 3.3 X 10(-8) M, respectively. The TeBG capacity in these patients was significantly higher and the free T concentration significantly lower (p less than 0.001) than those of the younger normal males. After treatment with 12 g diethylstilbestrol diphosphate and orchidectomy, the TeBG increased to 33.3 +/- 13.1 X 10(-8) M and the plasma free T concentration decreased to the minimal value of 0.053 +/- 0.04 ng/100 ml.
Similar articles
-
[Testosterone-binding capacity, free-plasma testosterone fraction, and free-plasma testosterone concentration in andrological patients (author's transl)].Dtsch Med Wochenschr. 1976 Jan 9;101(2):37-42. doi: 10.1055/s-0028-1104030. Dtsch Med Wochenschr. 1976. PMID: 1245153 German.
-
Effect of fluoxymesterone on the pituitary-gonadal axis: the role of testosterone-estradiol-binding globulin.J Clin Endocrinol Metab. 1976 Jul;43(1):1-9. doi: 10.1210/jcem-43-1-1. J Clin Endocrinol Metab. 1976. PMID: 947929
-
A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.J Androl. 1998 Nov-Dec;19(6):761-8. J Androl. 1998. PMID: 9876028
-
Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.Urology. 2006 Dec;68(6):1263-7. doi: 10.1016/j.urology.2006.08.1058. Urology. 2006. PMID: 17169647
-
[Total testosterone, free testosterone].Nihon Rinsho. 1999 Dec;57 Suppl:279-82. Nihon Rinsho. 1999. PMID: 10778117 Review. Japanese. No abstract available.
Cited by
-
Plasma testosterone levels before and after stimulation with HCG in anorchism.Int Urol Nephrol. 1979;11(1):57-60. doi: 10.1007/BF02082812. Int Urol Nephrol. 1979. PMID: 157340
-
Reversibility in male idiopathic osteoporosis possible.Endocrinol Diabetes Metab Case Rep. 2023 Apr 19;2023(2):22-0407. doi: 10.1530/EDM-22-0407. Print 2023 Apr 1. Endocrinol Diabetes Metab Case Rep. 2023. PMID: 37073856 Free PMC article.